Orgenesis Inc. (ORGS)
OTCMKTS · Delayed Price · Currency is USD
0.0567
+0.0563 (14,075.00%)
At close: Oct 15, 2026
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $555.63 thousand as of October 15, 2026. It is the 52,065th most valuable company in the world and the 8,108th biggest in the United States. Its market cap has decreased by 91.54% in one year.
Market Cap
555.63K
Enterprise Value
18.70M
Revenue
1.04M
Global Rank
Country Rank
#8,108 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 28, 2010, Orgenesis's market cap has increased from 252.93K to 555.63K, an increase of 119.68%. That is a compound annual growth rate of 4.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 555.63K | -43.60% |
| Dec 31, 2025 | 985.22K | -89.92% |
| Dec 31, 2024 | 9.77M | -38.79% |
| Dec 29, 2023 | 15.96M | -67.96% |
| Dec 30, 2022 | 49.81M | -28.75% |
| Dec 31, 2021 | 69.91M | -35.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arno Therapeutics | 4.98K |
| Affimed | 4.92K |
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |
| Evelo Biosciences | 3.80K |
| Synovics Pharmaceuticals | 3.65K |